Compound 1651
Identifiers
- Canonical SMILES:
CCOc1cc(CNCCO)cc(Br)c1OCc1ccc(Cl)cc1Cl
- IUPAC name:
2-[({3-bromo-4-[(2,4-dichlorophenyl)methoxy]-5-ethoxyphenyl}methyl)amino]ethanol
- InChi:
InChI=1S/C18H20BrCl2NO3/c1-2-24-17-8-12(10-22-5-6-23)7-15(19)18(17)25-11-13-3-4-14(20)9-16(13)21/h3-4,7-9,22-23H,2,5-6,10-11H2,1H3
- InChiKey:
LSEBIOJOUZJDNG-UHFFFAOYSA-N
External links
![]() 2200479 |
![]() CHEMBL1621063 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
NRP / VEGF | 4.97 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 447.00 g/mol | |||
HBA | 4 | |||
HBD | 2 | |||
HBA + HBD | 6 | |||
AlogP | 4.58 | |||
TPSA | 50.72 | |||
RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4882 | Pinaverium | DB09090 | |
0.4500 | Priralfinamide | DB06649 | |
0.4500 | Safinamide | DB06654 | |
0.4454 | Itopride | DB04924 | |
0.4412 | Fipexide | DB13790 | |
0.4309 | Trimethobenzamide | DB00662 | |
0.4210 | Dibrompropamidine | DB13548 | |
0.4144 | Etamivan | DB08989 | |
0.4138 | Trimetazidine | DB09069 | |
0.4114 | N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide | DB07738 | |
0.4095 | Bephenium | DB13462 | |
0.4056 | [3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid | DB02106 | |
0.3955 | Bitolterol | DB00901 | |
0.3947 | Piclamilast | DB01791 | |
0.3913 | Phenoxybenzamine | DB00925 |